AbstractPolysaccharide-based device for oral delivery of heparin (HP) was successfully prepared. Previously synthesized N,N-dimethyl chitosan (DMC) (86% dimethylated by 1H NMR spectroscopy) was complexed with HP by mixing HP and DMC aqueous solutions (both at pH 3.0). The polyelectrolyte complex (PEC) obtention was confirmed by infrared spectroscopy (FTIR), thermogravimetric analysis (TGA/DTG) and wide-angle X-ray scattering (WAXS). In vitro controlled release assays of HP from PEC were investigated in the simulated intestinal fluid (SIF) and simulated gastric fluid (SGF). The PEC efficiently protected the HP in SGF condition in which HP is degraded. On the other hand, in SIF PEC promoted the releasing of 80±1.5% of loaded HP. The promissor...
Purpose: Oral delivery of Heparin, the most potent anticoagulant drug, could have a great clinical i...
Modified carboxymethyl chitosan (CMC) containing phosphatidylethanolamine (PEA) groups were synthesi...
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Ci...
Chitosan has been extensively studied as a genetic drug delivery platform. However, its efficiency i...
AbstractThis work deals with the preparation of chitosan/tripolyphosphate microparticles (CHT/TPP) u...
Enhanced oral bioavailability of poorly aqueous soluble drugs encapsulated in a number of lipid-base...
Objective: The objective of the present study was to prepare and evaluate a novel oral formulation o...
Enhancing oral bioavailability of hydrophilic drugs by encapsulation in lipid-based nanocarriers, in...
Heparin is still widely used for treatment and prevention of thromboembolic diseases. Due to specifi...
Enhanced oral bioavailability of poorly aqueous soluble drugs encapsulated in a number of lipid-base...
Heparin, as therapeutic medications, cannot be administered orally because of its hydrophilic and hi...
AbstractThe aim of this study was to develop hepatocyte-targeting non-viral polymeric nono-carriers ...
Heparin is a commonly applied blood anticoagulant agent in clinical use. After treatment, excess hep...
The aim of this study was to evaluate the performance of chitosan (CS) and glycol chitosan (GCS) nan...
The delivery of growth factors has been attempted for a number of different therapies. The approach...
Purpose: Oral delivery of Heparin, the most potent anticoagulant drug, could have a great clinical i...
Modified carboxymethyl chitosan (CMC) containing phosphatidylethanolamine (PEA) groups were synthesi...
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Ci...
Chitosan has been extensively studied as a genetic drug delivery platform. However, its efficiency i...
AbstractThis work deals with the preparation of chitosan/tripolyphosphate microparticles (CHT/TPP) u...
Enhanced oral bioavailability of poorly aqueous soluble drugs encapsulated in a number of lipid-base...
Objective: The objective of the present study was to prepare and evaluate a novel oral formulation o...
Enhancing oral bioavailability of hydrophilic drugs by encapsulation in lipid-based nanocarriers, in...
Heparin is still widely used for treatment and prevention of thromboembolic diseases. Due to specifi...
Enhanced oral bioavailability of poorly aqueous soluble drugs encapsulated in a number of lipid-base...
Heparin, as therapeutic medications, cannot be administered orally because of its hydrophilic and hi...
AbstractThe aim of this study was to develop hepatocyte-targeting non-viral polymeric nono-carriers ...
Heparin is a commonly applied blood anticoagulant agent in clinical use. After treatment, excess hep...
The aim of this study was to evaluate the performance of chitosan (CS) and glycol chitosan (GCS) nan...
The delivery of growth factors has been attempted for a number of different therapies. The approach...
Purpose: Oral delivery of Heparin, the most potent anticoagulant drug, could have a great clinical i...
Modified carboxymethyl chitosan (CMC) containing phosphatidylethanolamine (PEA) groups were synthesi...
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Ci...